|
|
|
|
|
|
|
Minerva Neurosciences Inc. (NERV)
|
|
7.245 -0.095 (-1.29%)
|
12-18 10:30
|
|
Open:
|
7.44
|
Pre. Close:
|
7.34
|
|
High:
|
7.44
|
Low:
|
7.22
|
|
Volume:
|
9,280
|
Market Cap:
|
282M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
7.81 - 7.848
|
7.848 - 7.885
|
|
Low:
|
7.134 - 7.179
|
7.179 - 7.224
|
|
Close:
|
7.255 - 7.328
|
7.328 - 7.399
|
|
|
|
Technical analysis (as of: 2018-12-18 10:25:09 AM)
|
|
Overall:
|
|
|
Stoxline posted a SELL today, same as yesterday. This stock seems to continue bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.
|
|
Target:
|
Six months: 10.03  One year: 11.01
|
|
Support:
|
Support1: 7.22 Support2: 6.01
|
|
Resistance:
|
Resistance1:
8.59 Resistance2: 9.43
|
|
Pivot:
|
7.85
|
|
Moving Averages:
|
MA(5): 7.63 MA(20): 8.03
MA(100): 9.66 MA(250): 8.05 
|
|
MACD:
|
MACD(12,26):
-0.51 Signal(12,26,9): -0.53
|
|
%K %D:
|
%K(14,3): 7.26 %D(3): 11.36
|
|
RSI:
|
RSI(14): 29.62
|
|
52-Week:
|
High: 12.95
Low: 5 Change(%): 28.1
|
|
Average Vol(K):
|
3-Month: 17433
10-Days 12826
|
|
|
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.NERV has closed below the lower band by 11.6%. If price is in a downtrend band; this downward trend in price might continue. However a short term pullback inside the band is likely. Bollinger Bands are 55.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to NERV's normal range. The bands have been in this narrow range for 2 bars. This is a sign that the market may be about to initiate a new trend.
|
|
|
Headline News
|
|
2018-11-19T10:05:41-05:00
Early-stage study shows potential expanded therapeutic window for Minerva's roluperidone
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
NA
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
